2025 National Medical Insurance Negotiations Kick Off with Introduction of "Commercial Insurance Innovative Drug List" Mechanism

Deep News

Oct 30

The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30.

This year’s negotiations mark the first official introduction of the "Commercial Insurance Innovative Drug List" mechanism, building upon the existing routine adjustments to the medical insurance catalog. The new list focuses on innovative drugs that exceed basic coverage criteria and are temporarily ineligible for inclusion in the essential catalog but demonstrate high innovation, significant clinical value, and substantial patient benefits. These drugs are recommended for reference by multi-tiered medical security systems, including commercial health insurance and medical mutual aid programs.

According to an August 28 announcement by the National Healthcare Security Administration, 535 generic drug names passed the formal review for the 2025 Essential Drug List adjustment. Meanwhile, 121 generic drug names qualified for the Commercial Insurance Innovative Drug List, with 79 of them applying for both the basic medical insurance catalog and the new commercial insurance list.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1156670626"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156670626\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156670626?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156670626","market":"sh","top_or_hot":-1,"title":"2025 National Medical Insurance Negotiations Kick Off with Introduction of \"Commercial Insurance Innovative Drug List\" Mechanism","media":"Deep News","content":"<p>The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30.</p>\n<p>This year’s negotiations mark the first official introduction of the \"Commercial Insurance Innovative Drug List\" mechanism, building upon the existing routine adjustments to the medical insurance catalog. The new list focuses on innovative drugs that exceed basic coverage criteria and are temporarily ineligible for inclusion in the essential catalog but demonstrate high innovation, significant clinical value, and substantial patient benefits. These drugs are recommended for reference by multi-tiered medical security systems, including commercial health insurance and medical mutual aid programs.</p>\n<p>According to an August 28 announcement by the National Healthcare Security Administration, 535 generic drug names passed the formal review for the 2025 Essential Drug List adjustment. Meanwhile, 121 generic drug names qualified for the Commercial Insurance Innovative Drug List, with 79 of them applying for both the basic medical insurance catalog and the new commercial insurance list.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2025 National Medical Insurance Negotiations Kick Off with Introduction of \"Commercial Insurance Innovative Drug List\" Mechanism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2025 National Medical Insurance Negotiations Kick Off with Introduction of \"Commercial Insurance Innovative Drug List\" Mechanism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-10-30 10:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30.</p>\n<p>This year’s negotiations mark the first official introduction of the \"Commercial Insurance Innovative Drug List\" mechanism, building upon the existing routine adjustments to the medical insurance catalog. The new list focuses on innovative drugs that exceed basic coverage criteria and are temporarily ineligible for inclusion in the essential catalog but demonstrate high innovation, significant clinical value, and substantial patient benefits. These drugs are recommended for reference by multi-tiered medical security systems, including commercial health insurance and medical mutual aid programs.</p>\n<p>According to an August 28 announcement by the National Healthcare Security Administration, 535 generic drug names passed the formal review for the 2025 Essential Drug List adjustment. Meanwhile, 121 generic drug names qualified for the Commercial Insurance Innovative Drug List, with 79 of them applying for both the basic medical insurance catalog and the new commercial insurance list.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1156670626","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156670626","pubTimestamp":1761790838,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30. This year’s negotiations mark the first official introduction of the \"Commercial Insurance Innovative Drug List\"...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159992":"创新药","BK1161":"生物科技","06978":"永泰生物-B","BK1574":"生物医药B类股"},"translate_title":"2025年国家医保谈判拉开帷幕引入“商保创新药清单”机制","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"06978":1},"content_text":"The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30.\nThis year’s negotiations mark the first official introduction of the \"Commercial Insurance Innovative Drug List\" mechanism, building upon the existing routine adjustments to the medical insurance catalog. The new list focuses on innovative drugs that exceed basic coverage criteria and are temporarily ineligible for inclusion in the essential catalog but demonstrate high innovation, significant clinical value, and substantial patient benefits. These drugs are recommended for reference by multi-tiered medical security systems, including commercial health insurance and medical mutual aid programs.\nAccording to an August 28 announcement by the National Healthcare Security Administration, 535 generic drug names passed the formal review for the 2025 Essential Drug List adjustment. Meanwhile, 121 generic drug names qualified for the Commercial Insurance Innovative Drug List, with 79 of them applying for both the basic medical insurance catalog and the new commercial insurance list.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}